Stockscreener 앱 받기
9.68
2.22%
0.21
시장 영업 전:
9.60
-0.08
-0.83%
전일 마감가:
$9.47
열려 있는:
$9.45
하루 거래량:
1.53M
Relative Volume:
0.70
시가총액:
$1.11B
수익:
$2.35B
순이익/손실:
$-74.42M
주가수익비율:
-10.30
EPS:
-0.94
순현금흐름:
$150.93M
1주 성능:
+3.75%
1개월 성능:
+7.68%
6개월 성능:
-64.21%
1년 성능:
-69.68%
1일 변동 폭
$9.33
$9.85
1주일 범위
$9.28
$9.85
52주 변동 폭
$8.23
$33.48
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
EVH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.68 | 1.11B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
227.90 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.72 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
47.22 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
87.05 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.94 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
Is Evolent Health (EVH) About to Explode? - Insider Monkey
12 Stocks That Are About to Explode - Insider Monkey
Here’s What Challenged Evolent Health (EVH) Despite Strong Revenue Growth - Insider Monkey
Evolent Health (NYSE:EVH) shareholders have endured a 69% loss from investing in the stock a year ago - Yahoo Finance
When the Price of (EVH) Talks, People Listen - Stock Traders Daily
1 Healthcare Stock on Our Watchlist and 2 to Turn Down - The Globe and Mail
Evolent Health (EVH): Among Stocks Insiders Are Buying In March - Insider Monkey
Evolent Health Co-Founder Acquires 13% More Stock - simplywall.st
10 Stocks Insiders Are Buying In March - Insider Monkey
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) - The Globe and Mail
Commit To Buy Evolent Health At $7.50, Earn 22.1% Annualized Using Options - Nasdaq
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Healthcare Powerhouse Carolyn Magill Joins $800M Define Ventures Leadership Team - StockTitan
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa
Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock By Investing.com - Investing.com South Africa
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga
Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia
Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada
Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com South Africa
Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com
Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com South Africa
Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India
Evolent health director Diane Holder buys shares worth $25,517 - Investing.com India
Evolent Health CEO Seth Blackley purchases $497,577 in stock - Investing.com India
Evolent Health director Keck Kim buys $99,497 in stock - Investing.com India
Evolent health director Jelinek acquires $273,750 in stock - Investing.com India
Evolent Health price target lowered to $12 from $13 at JPMorgan - TipRanks
Evolent Health Executives and Directors Acquire Shares - TradingView
Evolent Health Insider Bought Shares Worth $273,750, According to a Recent SEC Filing - Marketscreener.com
Evolent Health Insider Bought Shares Worth $497,577, According to a Recent SEC Filing - Marketscreener.com
Evolent Health Executives Increase Holdings Through Recent Stock Purchases - TradingView
Evolent Health director Craig Barbarosh buys $17,620 in stock - Investing.com
Evolent health director Brendan Springstubb acquires $139,050 in stock - Investing.com
3 Reasons to Sell EVH and 1 Stock to Buy Instead - The Globe and Mail
Challenges Persist for Evolent Health as Stock PlummetsNews and Statistics - IndexBox, Inc.
Evolent Health, Inc. (NYSE:EVH) Position Raised by Principal Financial Group Inc. - Defense World
Upcoming Events - Financial Content
Evolent Health (NYSE:EVH) Trading 4.9% Higher on Insider Buying Activity - Defense World
Insider Buying: Brendan Springstubb Acquires Shares of Evolent H - GuruFocus.com
Director Makes Bold Move with Major Evolent Health Stock Purchase - TipRanks
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.83%
자본화:
|
볼륨(24시간):